Literature DB >> 17634448

Complement C3 variant and the risk of age-related macular degeneration.

John R W Yates1, Tiina Sepp, Baljinder K Matharu, Jane C Khan, Deborah A Thurlby, Humma Shahid, David G Clayton, Caroline Hayward, Joanne Morgan, Alan F Wright, Ana Maria Armbrecht, Baljean Dhillon, Ian J Deary, Elizabeth Redmond, Alan C Bird, Anthony T Moore.   

Abstract

BACKGROUND: Age-related macular degeneration is the most common cause of blindness in Western populations. Susceptibility is influenced by age and by genetic and environmental factors. Complement activation is implicated in the pathogenesis.
METHODS: We tested for an association between age-related macular degeneration and 13 single-nucleotide polymorphisms (SNPs) spanning the complement genes C3 and C5 in case subjects and control subjects from the southeastern region of England. All subjects were examined by an ophthalmologist and had independent grading of fundus photographs to confirm their disease status. To test for replication of the most significant findings, we genotyped a set of Scottish cases and controls.
RESULTS: The common functional polymorphism rs2230199 (Arg80Gly) in the C3 gene, corresponding to the electrophoretic variants C3S (slow) and C3F (fast), was strongly associated with age-related macular degeneration in both the English group (603 cases and 350 controls, P=5.9x10(-5)) and the Scottish group (244 cases and 351 controls, P=5.0x10(-5)). The odds ratio for age-related macular degeneration in C3 S/F heterozygotes as compared with S/S homozygotes was 1.7 (95% confidence interval [CI], 1.3 to 2.1); for F/F homozygotes, the odds ratio was 2.6 (95% CI, 1.6 to 4.1). The estimated population attributable risk for C3F was 22%.
CONCLUSIONS: Complement C3 is important in the pathogenesis of age-related macular degeneration. This finding further underscores the influence of the complement pathway in the pathogenesis of this disease. Copyright 2007 Massachusetts Medical Society.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17634448     DOI: 10.1056/NEJMoa072618

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  379 in total

1.  Matrix metalloproteinase activity creates pro-angiogenic environment in primary human retinal pigment epithelial cells exposed to complement.

Authors:  Mausumi Bandyopadhyay; Bärbel Rohrer
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-18       Impact factor: 4.799

2.  Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models.

Authors:  Yi Yu; Robyn Reynolds; Bernard Rosner; Mark J Daly; Johanna M Seddon
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-21       Impact factor: 4.799

Review 3.  Complement dysregulation in AMD: RPE-Bruch's membrane-choroid.

Authors:  Janet R Sparrow; Keiko Ueda; Jilin Zhou
Journal:  Mol Aspects Med       Date:  2012-04-05

Review 4.  How does the macula protect itself from oxidative stress?

Authors:  James T Handa
Journal:  Mol Aspects Med       Date:  2012-04-05

Review 5.  Current gene discovery strategies for ocular conditions.

Authors:  Priya Duggal; Grace Ibay; Alison P Klein
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

Review 6.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

Review 7.  Therapeutic targets in age-related macular disease.

Authors:  Alan C Bird
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

8.  Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study.

Authors:  Zohar Yehoshua; Carlos Alexandre de Amorim Garcia Filho; Renata Portella Nunes; Giovanni Gregori; Fernando M Penha; Andrew A Moshfeghi; Kang Zhang; Srinivas Sadda; William Feuer; Philip J Rosenfeld
Journal:  Ophthalmology       Date:  2013-11-26       Impact factor: 12.079

Review 9.  Age-related macular degeneration: genetics and biology coming together.

Authors:  Lars G Fritsche; Robert N Fariss; Dwight Stambolian; Gonçalo R Abecasis; Christine A Curcio; Anand Swaroop
Journal:  Annu Rev Genomics Hum Genet       Date:  2014-04-16       Impact factor: 8.929

10.  Search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways.

Authors:  Mark W Logue; Matthew Schu; Badri N Vardarajan; John Farrell; Kathryn L Lunetta; Gyungah Jun; Clinton T Baldwin; Margaret M Deangelis; Lindsay A Farrer
Journal:  Neurobiol Aging       Date:  2013-12-19       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.